News UK grants patients early access to AbbVie/Roche leukaemia dr... Venetoclax still under review in Europe.
News CNS-focused Supernus and Indivior agree merger terms Supernus Pharma and Indivior have signed an all-stock merger agreement that would establish a new CNS-focused company with annual sales of $2.2bn.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
